ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Report Urges Heated Chemo To Optimize Patient Survival

November 24, 2006

Letter; ASSIST Prevents Cancer, Should Remain in NCI Portfolio

July 4, 1997

FDA Urges Moratorium On Sale, Use of Silicone Breast Implants

January 10, 1992

Funding Opportunities.

March 15, 2002

Abstracts of ‘Most Newsworthy’ Papers

June 3, 1977

NCI Cancer Education Program To Open To Innovative Ideas

April 2, 1993